Maternal and fetal outcomes following exposure to duloxetine in pregnancy: cohort study

Use of real‐world evidence from healthcare utilization data to evaluate drug safety during pregnancy

(2019) Krista F. Huybrechts et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

A Propensity-score-based Fine Stratification Approach for Confounding Adjustment When Exposure Is Infrequent

(2017) Rishi J. Desai et al.   EPIDEMIOLOGY

Lithium Use in Pregnancy and the Risk of Cardiac Malformations

(2017) Elisabetta Patorno et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort

(2017) Anick Bérard et al.   BMJ Open

First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review

(2015) Dorte Lassen et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Antidepressant Use in Pregnancy and the Risk of Cardiac Defects

(2014) Krista F. Huybrechts et al.   NEW ENGLAND JOURNAL OF MEDICINE

Validity of maternal and infant outcomes within nationwide Medicaid data

(2014) Kristin Palmsten et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Duloxetine and Pregnancy Outcomes: Safety Surveillance Findings

(2013) Sharon L Hoog et al.   International Journal of Medical Sciences

Validation of an algorithm to estimate gestational age in electronic health plan databases

(2013) Qian Li et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Harnessing the Medicaid Analytic eXtract (MAX) to Evaluate Medications in Pregnancy: Design Considerations

(2013) Kristin Palmsten et al.   PLoS One

Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion – A Population-Based Study

(2013) Maiken Ina Siegismund Kjaersgaard et al.   PLoS One

Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States

(2013) K. Palmsten et al.   BMJ-British Medical Journal

Rates of Major Malformations in Infants Following Exposure to Duloxetine During Pregnancy

(2012) Adrienne Einarson et al.   JOURNAL OF CLINICAL PSYCHIATRY

First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: A meta-analysis of epidemiological studies

(2009) Keele E. Wurst et al.   BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY

Using the Standardized Difference to Compare the Prevalence of a Binary Variable Between Two Groups in Observational Research

(2009) Peter C. Austin   COMMUNICATIONS IN STATISTICS-SIMULATION AND COMPUTATION

High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

(2009) Sebastian Schneeweiss et al.   EPIDEMIOLOGY

Positive predictive value of computerized records for major congenital malformations

(2007) William O. Cooper et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY